Dublin, March 11, 2021 (GLOBE NEWSWIRE) -- The "Epilepsy Drugs - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Amid the COVID-19 crisis, the global market for Epilepsy Drugs estimated at US$ 4.6 Billion in the year 2020, is projected to reach a revised size of US$ 5.8 Billion by 2027, growing at a CAGR of 3.3% over the analysis period 2020-2027. First Generation, one of the segments analyzed in the report, is projected to record a 2.5% CAGR and reach US$ 1.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Second Generation segment is readjusted to a revised 3.2% CAGR for the next 7-year period.
The Epilepsy Drugs market in the U.S. is estimated at US$ 1.3 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$ 1.1 Billion by the year 2027 trailing a CAGR of 5.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2% and 2.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.
In the global Third Generation segment, USA, Canada, Japan, China and Europe will drive the 3.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$ 1.2 Billion in the year 2020 will reach a projected size of US$ 1.5 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.
Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$ 752.6 Million by the year 2027, while Latin America will expand at a 4.2% CAGR through the analysis period.
Select Competitors (Total 42 Featured):
Abbott Laboratories, Inc.
Johnson & Johnson
Sanofi Aventis S.A.
Tansna Therapeutics, Inc.
UCB Pharma, Inc.
Key Topics Covered:
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Global Competitor Market Shares
Epilepsy Drugs Competitor Market Share Scenario Worldwide (in %): 2020E
Global Competitor Market Shares by Segment
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Total Companies Profiled: 42
For more information about this report visit https://www.researchandmarkets.com/r/6f348c
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900